Advances in Oncology, 2026, 1st Edition

Authors

Leonidas C. Platanias (Editor)

⚠️ PRINT ON DEMAND — DELIVERY CAN TAKE UP TO 10 DAYS

ISBN: 9780443470509

Published: May 12, 2026

Format: Hardcover

Language: English

Publisher: Elsevier

Description

Advances in Oncology, 2026 is the first volume of a new Elsevier annual review series in oncology, edited by Dr. Leonidas C. Platanias, Director of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University. The volume brings together 25 focused review articles from leading specialists, distilling the year's most significant clinical advances and points of ongoing debate, with an emphasis on translating research findings into practical guidance for day-to-day patient care.

Key Features

25 focused review articles spanning topics such as gallbladder cancer management, palliative radiation therapy, circulating tumor DNA in gynecologic malignancies, hormonal contraception and meningioma risk, MRD-guided treatment for newly diagnosed CLL in younger adults, emerging therapies for non-muscle invasive bladder cancer, and treatment strategies for older adults with GI cancers, among other topics.

In-depth clinical reviews offering actionable insights for everyday oncology practice.

Contributions from an experienced editorial board that synthesizes the latest research and practice guidelines into accessible, topic-based overviews.

Table of Contents

Radiation Therapy to Prolong Systemic Therapy Benefit Across Solid Tumors
Management of Desmoid Tumors
Management of Advanced Thyroid Cancer: An Update
Current State and Future Therapeutic Opportunities for Gallbladder Cancer
Role of Circulating Tumor DNA as a Tool in the Management of GYN Malignancies
Gestational Trophoblastic Neoplasia: A Review of the Evidence and Emerging Therapies
Application and Considerations for an Evolving Therapeutic Landscape
Beyond CD19: New Targets for CAR T-cell Therapy in Acute Myeloid Leukemia
Brachytherapy for Gliomas: A Rekindle
Neurologic Complications in Immuno-oncology: Chimeric Antigen Receptor T-Cell Therapies and T-Cell Engagers
A Fixed-Duration Bispecific Antibody Strategy for Treatment of Multiple Myeloma
Measurable Residual Disease-Driven Approach to Frontline Treatment for Chronic Lymphocytic Leukemia in Younger and/or Fit Patients
Treatment Approaches and Future Directions for Neuroendocrine Prostate Cancer and Other Aggressive Variant Prostate Cancers
Non-clear Cell Renal Cell Carcinoma: Current Knowledge and Future Directions
Current Interventional Radiology Strategies for Liver Metastases
De-escalation Treatment Strategies for Gastrointestinal Malignancies
Contemporary Approaches to the Care of Older Adults with Gastrointestinal Cancers

About the Author

Leonidas C. Platanias, M.D., Ph.D, is Director of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University and Professor of Medicine (Hematology and Oncology) and Biochemistry and Molecular Genetics.

Why buy this book?

For oncology departments, cancer centers, and medical libraries, this inaugural volume offers a single curated reference distilling a full year of clinically relevant oncology research, helping practitioners stay current on evolving standards of care without tracking dozens of individual journal publications.

Keywords

oncology, cancer treatment, clinical oncology, gallbladder cancer, gynecologic malignancies, CAR T-cell therapy, chronic lymphocytic leukemia, prostate cancer, renal cell carcinoma, gastrointestinal cancers, cancer therapeutics 2026

Target Audience

practicing oncologists, hematology-oncology fellows, cancer center faculty, medical oncology libraries

Genre

Medicine, Oncology, Clinical Reference

Q&A

What does Advances in Oncology, 2026 cover?
It reviews the most clinically significant oncology research and practice updates from the past year, spanning solid tumors, hematologic malignancies, and emerging cell-based therapies.

Who edited Advances in Oncology, 2026?
The volume is edited by Dr. Leonidas C. Platanias, Director of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University.

Is Advances in Oncology, 2026 suitable for practicing oncologists?
Yes — it is designed to bring the latest research to a clinical level, with actionable insights for day-to-day oncology practice.

How many articles does this volume contain?
25 original review articles covering major areas of progress and controversy in oncology.

Does this book cover CAR T-cell therapy advances?
Yes — it includes dedicated reviews on CAR T-cell therapy in acute myeloid leukemia and on neurologic complications of CAR T-cell and T-cell engager therapies.

Where can I buy Advances in Oncology, 2026?

Advances in Oncology, 2026 is available for purchase directly from CLNZ Books, with worldwide delivery to university libraries, cancer centers, and individual oncology professionals.

📘 Learn more about shipping, delivery times, and returns, see our FAQ here

How to Order